MCRB – Seres Therapeutics, Inc.
MCRB — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
8.84
Margin Of Safety %
41
Put/Call OI Ratio
0.36
EPS Next Q Diff
-0.22
EPS Last/This Y
-8.87
EPS This/Next Y
-0.94
Price
9.1
Target Price
21
Analyst Recom
2
Performance Q
-41.18
Upside
17.0%
Beta
0.23
Ticker: MCRB
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | MCRB | 8.78 | 0.37 | 1.50 | 6233 |
| 2026-03-02 | MCRB | 9.06 | 0.37 | 0.17 | 6237 |
| 2026-03-03 | MCRB | 8.83 | 0.37 | 0.17 | 6237 |
| 2026-03-04 | MCRB | 9.15 | 0.37 | 0.19 | 6241 |
| 2026-03-05 | MCRB | 9.59 | 0.37 | 999.99 | 6231 |
| 2026-03-06 | MCRB | 9.06 | 0.37 | 0.25 | 6233 |
| 2026-03-09 | MCRB | 9.19 | 0.37 | 0.00 | 6241 |
| 2026-03-10 | MCRB | 9.01 | 0.37 | 0.03 | 6254 |
| 2026-03-11 | MCRB | 8.8 | 0.37 | 0.18 | 6318 |
| 2026-03-12 | MCRB | 8.99 | 0.37 | 0.00 | 6320 |
| 2026-03-13 | MCRB | 9.05 | 0.37 | 0.00 | 6320 |
| 2026-03-17 | MCRB | 9.44 | 0.36 | 0.38 | 6300 |
| 2026-03-18 | MCRB | 9.15 | 0.36 | 6.00 | 6306 |
| 2026-03-19 | MCRB | 9.07 | 0.36 | 999.99 | 6303 |
| 2026-03-20 | MCRB | 8.55 | 0.36 | 999.99 | 6307 |
| 2026-03-23 | MCRB | 8.59 | 0.36 | 0.00 | 6217 |
| 2026-03-24 | MCRB | 8.46 | 0.36 | 0.27 | 6225 |
| 2026-03-25 | MCRB | 9.2 | 0.36 | 0.08 | 6224 |
| 2026-03-26 | MCRB | 9.32 | 0.36 | 0.33 | 6309 |
| 2026-03-27 | MCRB | 9.08 | 0.36 | 2.67 | 6314 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | MCRB | 8.75 | 27.3 | - | 0.77 |
| 2026-03-02 | MCRB | 9.01 | 27.3 | - | 0.77 |
| 2026-03-03 | MCRB | 8.86 | 27.3 | - | 0.77 |
| 2026-03-04 | MCRB | 9.11 | 27.3 | - | 0.77 |
| 2026-03-05 | MCRB | 9.60 | 27.3 | - | 0.77 |
| 2026-03-06 | MCRB | 9.18 | 27.3 | - | 0.77 |
| 2026-03-09 | MCRB | 9.17 | 27.3 | - | 0.77 |
| 2026-03-10 | MCRB | 8.94 | 27.3 | - | 0.77 |
| 2026-03-11 | MCRB | 8.93 | 27.3 | - | 0.77 |
| 2026-03-12 | MCRB | 8.95 | 27.3 | - | 0.77 |
| 2026-03-13 | MCRB | 8.64 | - | - | -7.97 |
| 2026-03-17 | MCRB | 9.42 | - | - | -7.97 |
| 2026-03-18 | MCRB | 9.06 | - | - | -7.97 |
| 2026-03-19 | MCRB | 8.95 | - | - | -7.97 |
| 2026-03-20 | MCRB | 8.49 | 16.0 | - | -8.23 |
| 2026-03-23 | MCRB | 8.59 | 16.0 | - | -8.23 |
| 2026-03-24 | MCRB | 8.37 | 16.0 | - | -8.23 |
| 2026-03-25 | MCRB | 9.14 | 16.0 | - | -8.23 |
| 2026-03-26 | MCRB | 9.34 | 16.0 | - | -8.23 |
| 2026-03-27 | MCRB | 9.10 | 16.0 | - | -8.23 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-02 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-03 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-04 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-05 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-06 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-09 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-10 | MCRB | -0.13 | 3.73 | 11.54 |
| 2026-03-11 | MCRB | -0.13 | 3.73 | 9.76 |
| 2026-03-12 | MCRB | -0.13 | 3.73 | 9.76 |
| 2026-03-13 | MCRB | -0.13 | 3.73 | 9.76 |
| 2026-03-17 | MCRB | -0.12 | 3.51 | 9.21 |
| 2026-03-18 | MCRB | -0.12 | 3.51 | 9.21 |
| 2026-03-19 | MCRB | -0.12 | 3.51 | 9.21 |
| 2026-03-20 | MCRB | -0.12 | 3.51 | 9.21 |
| 2026-03-23 | MCRB | -0.12 | 3.54 | 9.21 |
| 2026-03-24 | MCRB | -0.12 | 3.54 | 9.21 |
| 2026-03-25 | MCRB | -0.12 | 3.54 | 8.84 |
| 2026-03-26 | MCRB | -0.12 | 3.54 | 8.84 |
| 2026-03-27 | MCRB | -0.12 | 3.54 | 8.84 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.89
Avg. EPS Est. Current Quarter
-1.88
Avg. EPS Est. Next Quarter
-2.11
Insider Transactions
-0.12
Institutional Transactions
3.54
Beta
0.23
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
12.88
Quality Score
38
Growth Score
21
Sentiment Score
51
Actual DrawDown %
98.2
Max Drawdown 5-Year %
-98.6
Target Price
21
P/E
11.11
Forward P/E
PEG
P/S
109.21
P/B
1.95
P/Free Cash Flow
100.32
EPS
0.81
Average EPS Est. Cur. Y
-8.23
EPS Next Y. (Est.)
-9.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
721.93
Relative Volume
0.51
Return on Equity vs Sector %
-14.5
Return on Equity vs Industry %
1.8
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
2.2
EBIT Estimation
◆
MCRB
Healthcare
$9.00
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.9
Range 1M
63.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-1342.2%
EPS NY
-15.4%
52W%
10.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+79.2% upside
Upside
+79.2%
Quality
38
MoS
41%
Seres Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 66
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
MCRB
Latest News
—
Caricamento notizie per MCRB…
stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today
news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance
stock history MCRB – Seres Therapeutics, Inc. invest stock market
stock prices MCRB premarket after hours
ticker MCRB fair value insiders trading